Wealthcare Advisory Partners’s Emergent Biosolutions EBS Stock Holding History

Wealthcare Advisory Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$5K	–	1321
2019 Q1	$5K	Hold	100	–	–	﹤0.01%	958
2018 Q4	$6K	Hold	100	–	–	﹤0.01%	886
2018 Q3	$7K	Hold	100	–	–	﹤0.01%	926
2018 Q2	$5K	Hold	100	–	–	﹤0.01%	972
2018 Q1	$5K	Hold	100	–	–	﹤0.01%	823
2017 Q4	$5K	Hold	100	–	–	﹤0.01%	776
2017 Q3	$4K	Buy	+100	New	+$3.62K	﹤0.01%	674

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Wealthcare Advisory Partners's EBS Position: Q2 2019 in Review

Wealthcare Advisory Partners sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 100 shares — an estimated $5K sold.

Wealthcare Advisory Partners first reported a position in EBS in Q3 2017 and held it in 7 quarters. The position peaked at $7K in Q3 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

Wealthcare Advisory Partners reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
Wealthcare Advisory Partners sold 100 Emergent Biosolutions shares in Q2 2019, an estimated $5K.
Wealthcare Advisory Partners first reported a position in Emergent Biosolutions in Q3 2017 and held it in 7 quarters.
Wealthcare Advisory Partners's Emergent Biosolutions position peaked at $7K in Q3 2018.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2019, filed 30 Jul 2019.